Analystreport

Horizon Pharma PLC (NASDAQ: HZNP) had its price target raised by analysts at Stifel Nicolaus from $25.00 to $35.00. They now have a "buy" rating on the stock.

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report